Thalia Therapeutics wins Chinese patent for miRisten
Thalia Therapeutics wins Chinese patent for miRisten
Thalia Therapeutics (LSE:THAT) announced that China has granted a patent covering miRisten, its anti-microRNA-126 therapy for acute myeloid leukaemia (AML)…
dlvr.it
September 29, 2026 at 10:34 AM
Thalia Therapeutics wins Chinese patent for miRisten
Feed: "Business-News-Today.com"
By: Srinath on Sunday, July 19, 2026
By: Srinath on Sunday, July 19, 2026
Thalia Therapeutics (AIM: THAT) completes Sanmirna acquisition to add Phase 1 AML asset
Thalia completes the Sanmirna acquisition and funds miRisten Phase 1, but dilution, trial execution and future milestone payments now shape the upside.
business-news-today.com
July 19, 2026 at 6:31 PM
Feed: "Business-News-Today.com"
By: Srinath on Sunday, July 19, 2026
By: Srinath on Sunday, July 19, 2026
Poster session this afternoon with Mat Froid showing our work with Russ Rockne (City of Hope) modeling the #JanusEffect in Leukemia and how treatment with new drug #miristen can help if guided by a #MathOnco model #CSBCPSON23
November 8, 2023 at 12:40 AM
Poster session this afternoon with Mat Froid showing our work with Russ Rockne (City of Hope) modeling the #JanusEffect in Leukemia and how treatment with new drug #miristen can help if guided by a #MathOnco model #CSBCPSON23